Helen R. Salwen

SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.

Alexandre Chlenski, Shuqing Liu, Susan E. Crawford et al. · PubMed · 2002 · 163 citations

Medicine, Cancer Biology, Oncology +14

SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix

Alexandre Chlenski, Shuqing Liu, Lisa J. Guerrero et al. · International Journal of Cancer · 2005 · 115 citations · Full text

Medicine, Cell Biology, Oncology +12

MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN

Susan L. Cohn, Wendy B. London, Howard M. Katzenstein et al. · Journal of Clinical Oncology · 2000 · 112 citations

Medicine, Oncology, Pediatrics +14

Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma.

Qiwei Yang, Shuqing Liu, Yufeng Tian et al. · PubMed · 2003 · 109 citations

Medicine, Genetics, Oncology +17

Methylation of<i>CASP8, DCR2</i>, and<i>HIN-1</i>in Neuroblastoma Is Associated with Poor Outcome

Qiwei Yang, Colleen M. Kiernan, Yufeng Tian et al. · Clinical Cancer Research · 2007 · 104 citations

Medicine, Cancer Biology, Oncology +17